Literature DB >> 6820607

Humoral and cellular immunity in typhoid and paratyphoid carrier state, investigated by means of quantitative immunoelectrophoresis and in vitro stimulation of blood lymphocytes.

F Espersen, H H Mogensen, N Høiby, L Høj, J Greibe, S N Rasmussen, K Gaarslev.   

Abstract

The humoral and cellular immunity of 8 Salmonella carriers and 9 non-carriers was investigated and compared to findings in normal persons. The antibody response in serum and intestinal secretions was investigated by means of crossed immunoelectrophoresis, and blood lymphocytes were investigated by in vitro stimulation. Both carriers and non-carriers showed increased levels of precipitating antibodies as well as lymphocyte responses, when compared to normal persons. No differences in the antibody responses either qualitatively or quantitatively were found between carriers and non-carriers. Only few precipitins could be detected in intestinal secretions. Lymphocyte responses to S. typhi and S. paratyphi were significantly higher in carriers and non-carriers than in the controls. No significant difference in lymphocyte response to S. typhi, S. paratyphi and mitogens was obtained between carriers and non-carriers. Thus, the carrier state seems not due to detectable major immunodeficiency.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6820607     DOI: 10.1111/j.1699-0463.1982.tb01453.x

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Immunol Scand C        ISSN: 0108-0202


  2 in total

1.  Immunity to Salmonella typhi: considerations relevant to measurement of cellular immunity in typhoid-endemic regions.

Authors:  J R Murphy; S S Wasserman; S Baqar; L Schlesinger; C Ferreccio; A A Lindberg; M M Levine
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

Review 2.  Complex adaptive immunity to enteric fevers in humans: lessons learned and the path forward.

Authors:  Marcelo B Sztein; Rosangela Salerno-Goncalves; Monica A McArthur
Journal:  Front Immunol       Date:  2014-10-27       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.